1
Clinical Trials associated with Haploid allogeneic NK cell(Shanghai iCELL Biotechnology)Phase I Clinical Trial of Haploid Donor-derived in Vitro Activated Natural Killer Cells Infusion for Patients With Minimal Residual Disease After Consolidation Therapy for Acute Myeloid Leukemia
This trial will evaluate the effectiveness and safety of haploid donor-derived in vitro activated natural killer(NK) cells infusion for Treating acute myeloid leukemia Patients With minimal residual disease.
100 Clinical Results associated with Haploid allogeneic NK cell(Shanghai iCELL Biotechnology)
100 Translational Medicine associated with Haploid allogeneic NK cell(Shanghai iCELL Biotechnology)
100 Patents (Medical) associated with Haploid allogeneic NK cell(Shanghai iCELL Biotechnology)
100 Deals associated with Haploid allogeneic NK cell(Shanghai iCELL Biotechnology)